Time to experiment, time to clinic, and time to market are becoming even more important for developers and manufacturers of biopharmaceuticals. No matter the stage you are at, it is really key for you to hit your milestones as quickly as possible in the most effective way possible as your funding and ability to advance your science and ultimately get it to patients quickly depends on it. We recognize that many companies may not have all the knowledge/expertise needed in-house for R&D, process development and determining manufacturing options. And here, at Cytiva (formerly GE Healthcare Life Sciences), we want to make sure it is easy and quick to access enabling technologies, expertise and contract services to make those advancements happen.
- Caroline Auclaire-Daigle, Client Relationship Leader – National Programs & Business Services – NRC
- Ken Elder, Senior Account Manager – Cytiva
- Patrick McMahon, Business Development – Fast Trak Biomanufacturing Services
- Dr. Arun Raturi, CSO – Entos Pharmaceuticals